The breast cancer vaccine nelipepimut‐S employs the cytokine GM‐CSF as an adjuvant, which matures dendritic cells, but has the potential to stimulate myeloid‐derived suppressor cells, paradoxically suppressing cellular immunity.63 Here, CSF2 is linked to breast cancer.